Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.

@article{FriisMller2010PredictingTR,
  title={Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.},
  author={Nina Friis-M\oller and Rodolphe Thi{\'e}baut and Peter Reiss and Rainer K. Weber and Antonella d'Arminio Monforte and St{\'e}phane De Wit and Wafaa M El-Sadr and Eric Fontas and Signe Westring Worm and Ole Kirk and Andrew N Phillips and Caroline Sabin and Jens D. Lundgren and Matthew G. Law},
  journal={European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology},
  year={2010},
  volume={17 5},
  pages={491-501}
}
AIMS HIV-infected patients receiving combination antiretroviral therapy may experience metabolic complications, potentially increasing their risk of cardiovascular diseases (CVDs). Furthermore, exposures to some antiretroviral drugs seem to be independently associated with increased CVD risk. We aimed to develop cardiovascular risk-assessment models tailored to HIV-infected patients. METHODS AND RESULTS Prospective multinational cohort study. The data set included 22,625 HIV-infected patients… CONTINUE READING